Neuphoria Therapeutics Inc. · NASDAQ:NEUP
Armistice Capital, LLC's stake in Neuphoria Therapeutics Inc. fell to 4.99% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Armistice Capital, LLC's stake in Neuphoria Therapeutics Inc. fell to 4.99%, 1,033,796 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 4.99%
- Shares
- 1,033,796
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Armistice Capital, LLC | 4.99% | 1,033,796 |
| Steven Boyd | 4.99% | 1,033,796 |
Source
Related
- Neuphoria Therapeutics Inc.
- Armistice Capital, LLC
- Neuphoria Therapeutics Inc. shareholders
- Schedule 13G · AdvisorShares Trust · Oct 5, 2026
- Schedule 13G/A · Coastlands Capital LP · Jul 28, 2026
- Schedule 13G/A · Baselake Partners, LP · Feb 6, 2026
- Schedule 13D/A · Lynx1 Capital Management LP · Dec 29, 2025
- Schedule 13D/A · Lynx1 Capital Management LP · Dec 2, 2025